Literature DB >> 30579544

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients with Limited-Stage Small Cell Lung Cancer? - What the CONVERT Data Can Tell Us.

Judith van Loon1, Anne-Marie C Dingemans2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30579544     DOI： 10.1016/j.jtho.2018.11.005

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials.

Authors:  Qian Wu; Yiting Xiong; Shujuan Zhang; Xinling Chen; Fengming Yi; Yiping Wei; Wenxiong Zhang
Journal:  Front Oncol       Date:  2020-01-08       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.